Development of enzyme replacement therapy for Fabry disease with a modified α-N-acetylgalactosaminidase

被引：0
|
作者：
Sakuraba, Hitoshi [1 ]
机构：
[1] Meiji Pharmaceut Univ, Kiyose, Japan
来源：
MOLECULAR GENETICS AND METABOLISM | 2014年 / 111卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2013.12.224
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
212
引用
收藏
页码：S92 / S92
页数：1
相关论文
共 50 条
  • [41] Enzyme replacement therapy and intraepidermal innervation density in Fabry disease
    Schiffmann, Raphael
    Hauer, Peter
    Freeman, Barbara
    Ries, Markus
    Scott, Leland J. C.
    Polydefkis, Michael
    Brady, Roscoe O.
    McArthur, Justin C.
    Wagner, Kathryn
    MUSCLE & NERVE, 2006, 34 (01) : 53 - 56
  • [42] Enzyme replacement therapy reverses endothelial dysfunction in Fabry disease
    Shimizu, S.
    Shinoda, N.
    Tsuboi, K.
    Somura, F.
    Okamoto, R.
    Okumura, T.
    Maeda, K.
    Bando, Y. Kureishi
    Murohara, T.
    EUROPEAN HEART JOURNAL, 2013, 34 : 999 - 999
  • [43] Targeted nanoliposomes to improve enzyme replacement therapy of Fabry disease
    Tomsen-Melero, Judit
    Molto-Abad, Marc
    Merlo-Mas, Josep
    Diaz-Riascos, Zamira V.
    Cristobal-Lecina, Edgar
    Soldevila, Andreu
    Altendorfer-Kroath, Thomas
    Danino, Dganit
    Ionita, Inbal
    Pedersen, Jan Skov
    Snelling, Lyndsey
    Clay, Hazel
    Carreno, Aida
    Corchero, Jose L.
    Pulido, Daniel
    Casas, Josefina
    Veciana, Jaume
    Schwartz Jr, Simo
    Sala, Santi
    Font, Albert
    Birngruber, Thomas
    Royo, Miriam
    Cordoba, Alba
    Ventosa, Nora
    Abasolo, Ibane
    Gonzalez-Mira, Elisabet
    SCIENCE ADVANCES, 2024, 10 (50):
  • [44] Enzyme replacement therapy in Fabry disease in Poland: a position statement
    Nowicki, Michal
    Bazan-Socha, Stanislawa
    Blazejewska-Hyzorek, Beata
    Gellert, Ryszard
    Imiela, Jacek
    Kazmierczak, Jaroslaw
    Klopotowski, Mariusz
    Oko-Sarnowska, Zofia
    Pawlaczyk, Krzysztof
    Ponikowski, Piotr
    Slawek, Jaroslaw
    Sykut-Cegielska, Jolanta
    Witkowski, Adam
    Zwolinska, Danuta
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2020, 130 (01): : 91 - 97
  • [45] Two cases of Fabry disease and response to enzyme replacement therapy
    Ismail, F
    Orteu, C
    BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 : 26 - 26
  • [46] Enzyme replacement therapy for Fabry disease: proving the clinical benefit
    Breunig, F
    Wanner, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (01) : 7 - 9
  • [47] Increased frequency of enzyme replacement therapy in a Fabry disease cohort
    Henderson, Nadene D.
    Barch, Joshua
    Segady, Kayla
    Hoenig, Megan
    Ortiz, Damara
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (02) : S70 - S70
  • [48] Unravelling the mechanism of action of enzyme replacement therapy in Fabry disease
    Ko, Younhee
    Lee, CheolHo
    Moon, Myeong Hee
    Hong, Geu-Ru
    Cheon, Chong-Kun
    Lee, Jin-Sung
    JOURNAL OF HUMAN GENETICS, 2016, 61 (02) : 143 - 149
  • [49] Fabry disease, enzyme replacement therapy and the significance of antibody responses
    Deegan, Patrick B.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 (02) : 227 - 243
  • [50] Fabry disease in the era of enzyme replacement therapy: a renal perspective
    Cho, ME
    Kopp, JB
    PEDIATRIC NEPHROLOGY, 2004, 19 (06) : 583 - 593
12345